- Home
- FNWD vs TARA Comparison
FNWD vs TARA Comparison
Compare FNWD & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FNWD | TARA |
|---|---|---|
| Founded | 1994 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 143.6M | 165.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FNWD | TARA |
|---|---|---|
| Price | $39.08 | $5.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $34.00 | $20.33 |
| AVG Volume (30 Days) | 37.4K | ★ 1.3M |
| Earning Date | 01-27-2026 | 11-10-2025 |
| Dividend Yield | ★ 1.25% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.91 | N/A |
| Revenue | ★ $66,563,999.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.03 | N/A |
| P/E Ratio | $20.07 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $26.12 | $2.77 |
| 52 Week High | $39.99 | $7.82 |
Technical Indicators
Market Signals| Indicator | FNWD | TARA |
|---|---|---|
| Relative Strength Index (RSI) | 55.31 | 41.99 |
| Support Level | $38.44 | $5.07 |
| Resistance Level | $39.35 | $6.37 |
| Average True Range (ATR) | 1.14 | 0.43 |
| MACD | -0.20 | -0.19 |
| Stochastic Oscillator | 43.65 | 11.13 |
Price Performance
Historical ComparisonAbout FNWD Finward Bancorp
Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).